TP53 Co-Mutational Features and NGS-Calibrated Immunohistochemistry Threshold in Gastric Cancer.

OncoTargets and therapy(2021)

引用 1|浏览11
暂无评分
摘要
Our results indicated that exclusivity between and mutations could be potentially used as a cost-effective way to predict status. Also, setting proper IHC thresholds for each specific antibody is critical to accurately detect mutations and facilitate disease diagnosis.
更多
查看译文
关键词
TP53,co-mutation,gastric cancer,immunohistochemistry threshold,next-generation sequencing
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要